The clinical study of licorice flavonoid oil with light exercise on visceral fat reduction and safety evaluation. -Randomized, double-blind, placebo-controlled trial-

The clinical study of licorice flavonoid oil with light exercise on visceral fat reduction and safety evaluation. -Randomized, double-blind, placebo-controlled trial- - The clinical study of licorice flavonoid oil with light exercise on visceral fat reduction and safety evaluation.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028585

Enrollment

100

Registered

2019-01-01

Start date

2017-08-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

300mg/day of Licorice flavonoid oil capsule once at a day for 12 weeks Light exercise(active walking twice a week and take about 8,000 step walk other five days a week)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Healthy men and women between 20 and 65 years of age 2.BMI is between 23 and 30 3.Can do active walking about 30 min twice a week and take about 8,000 step walk other 5 days a week 4.Agreed the informed concent

Exclusion criteria

Exclusion criteria: 01.Under medication 02.Who can't stop to take supplements during the study 03.Who have severe disease(s) including kidney disease, heart disease, aspiration disorder, endocrine disease, diabetes, and metabolic syndrome 04.Who have an allergy to test substance 05.Drug addict and alcohol addict 06.Who have metal(s) in body around CT scan area 07.Who have in-plant medical device such as pace maker or AED 08.Feel fear to dark place (for CT scan) 09.Shift-worker, midnight-shift worker 10.Diagnosed familial hypercholesterolemia 11.Under pregnant, lactating, and potentially pregnant during the study 12.Who is attending another study using different food supplement(s), pharmaceutical(s), and cosmetic(s). Or attended/will attend another study within one month from agreed the informed consent 13.Person who is inappropriate for the study judged by medical doctor

Design outcomes

Primary

Measure	Time frame
Visceral fat area This item will be measured at baseline, 8 and 12 weeks months.	—

Countries

Japan

Contacts

Public ContactYoshoka Komori

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026